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Abstract 
Two-dimensional graphene offers interesting electronic, thermal and 
mechanical properties that are currently explored for advanced electronics, 
membranes and composites. Here we synthesize and explore the biological 
application of nano-graphene oxide (NGO), i.e. single-layer graphene oxide sheets 
down to a few nanometers in lateral width. We develop functionalization chemistry to 
impart solubility and compatibility of NGO in biological environments. We obtain 
size separated pegylated NGO sheets that are soluble in buffers and serum without 
agglomeration. The NGO sheets are found to be photoluminescent in the visible and 
infrared regions. The intrinsic photoluminescence (PL) of NGO is used for live cell 
imaging in the near-infrared (NIR) with little background. We found that simple 
physisorption via π-stacking can be used for loading doxorubicin, a widely used 
cancer drug onto NGO functionalized with antibody for selective cancer cell killing in 
vitro. Owing to the small size, intrinsic optical properties, large specific surface area, 
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low cost, and useful non-covalent interactions with aromatic drug molecules, NGO is 
a promising new material for biological and medical applications. 
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Introduction. 
The interesting physical properties of graphene, a novel one-atom-thick 
two-dimensional graphitic carbon system, has led to much excitement in recent years 
in material science and condensed-matter physics[1-6]. Potential applications of 
graphene for nanoelectronics [1, 3], sensors and nanocomposites[4, 5] have been actively 
pursued[6]. The biological application of graphene and graphene oxide (GO) remains 
unexplored and wide-open. There are several prerequisites for biological applications 
for a new material. First, rational functionalization chemistry is needed to impart 
graphene aqueous solubility and biocompatibility. GO and its chemically converted 
derivatives form stable suspensions in pure water but aggregate in salt or other 
biological solutions[6]. Second, graphene sheets with suitable sizes are desired. Size 
control or size separation at various length scales is necessary to suitably interface 
with biological systems in vitro or in vivo. Graphene and GO samples thus far are 
typically microns or larger in size. Lastly, little is known experimentally about the 
properties of graphene with molecular dimensions, on the order of ~10nm or below. 
The optical properties of graphene and GO are largely unexplored, a topic of 
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fundamental interest and could facilitate biological and medical research such as 
imaging. 
Here, we prepared ultrasmall graphene oxide down to <10nm in lateral 
dimension. We imparted aqueous stability to the NGO in buffer solutions and other 
biological media by covalently grafting polyethylene glycol (PEG) star-polymers onto 
the chemically activated surfaces and edges. A rate separation method was developed 
to separate the pegylated NGO according to physical dimension or size. Interestingly, 
the NGO sheets showed photoluminescence from visible to the near-infrared (NIR) 
range, which was used for cellular imaging with little background. Furthermore, an 
aromatic anti cancer drug doxorubicin was loaded onto the NGO sheets at a high 
capacity via simple physisorption. The drug was selectively shuttled into cancer cells 
by antibody conjugated NGO for selective cancer cell killing. 
 
Results and Discussion 
Our preparation of ultrasmall graphene sheets started from graphene oxide (GO) 
made by using a modified Hummer’s method (Fig. 1a, see Methods) [4-7]. Briefly, 
expandable graphite (Graftech Inc.) was used as starting material instead of graphite 
flakes for more uniform oxidization[3, 8]. The graphite powder was ground with NaCl 
salt crystals to reduce the particle size, and then soaked in sulfuric acid for 8h for 
intercalation. We then added oxidizing KMnO4, increased the oxidization temperature 
and extended the oxidization time to ~2h to make fully and uniformly oxidized 
graphite (see Supp. Info.). The products were washed with dilute acid and water. The 
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resulting GO after 1h sonication were mostly single layered (>70%, topographic 
height ~1.0nm) with 10-300nm in lateral width (Fig. 1b) according to AFM 
characterization. Previous work also attributed ~1.0nm thick GO to single-layered 
structures [3, 4, 6]. 
Infrared (IR) spectroscopy revealed the existence of –OH (~3400cm-1), C=O 
(1715cm-1), and C=C (1580cm-1)[9, 10] functional groups on as made GO (Fig.1d). We 
activated the GO sample with chloroacetic acid in a strong basic condition to activate 
epoxide and ester groups, and to convert the hydroxyl groups to carboxylic acid 
(–COOH).[11] The intermediate product, named GO-COOH, had increased water 
solubility and more carboxylic acids for consequent PEGylation (see Methods). Upon 
grafting PEG stars (6-arm branched PEG molecules) onto the –COOH groups, we 
obtained a product (NGO-PEG) with high solubility and stability in salt and cellular 
solutions, which is desirable for biological applications. Without pegylation, GO and 
GO-COOH suspensions immediately aggregated in salt and any other biological 
solutions. Atomic force microscopy (AFM) observed mostly <20nm in sheet size of 
NGO-PEG (Fig.1c), while the as-made GO sheets were 10-300nm in size (Fig.1b). 
The ultra-small size of the NGO was caused by sonication involved in GO-COOH 
making and PEGylation steps. IR characterization on carefully purified NGO-PEG 
sample indicated strong -CH2- (2870cm-1) vibrations due to PEG chains, and 
characteristic amide-carbonyl (NH-CO) stretching vibration (~1650cm-1, in Fig. 1d, 
labeled with an arrow.)[12], consistent with the grafting of PEG molecules on NGO 
sheets.  
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Activation and PEGylation of GO led to increases in optical absorption in the 
visible and near-infrared (VIS-NIR) range for the same starting graphitic carbon mass 
concentration (0.01mg/ml, Fig. 2a). The optical absorption peak at 230nm, originated 
from π-plasmon of carbon [13] [14], remained essentially the same. GO-COOH and 
NGO-PEG showed much higher absorbance in VIS-NIR range than GO. At 500nm, 
808nm and 1200nm, the absorbance of GO-COOH and NGO-PEG were 480%, 780% 
and 470% of GO, respectively. The significant increase in absorbance led to solution 
color change (darkening), visible to the eye (Fig. 2a inset). Such darkening was 
observed in hydrazine reduction of graphene oxide, and attributed to restoring of the 
electronic conjugation within the graphene sheets [4, 6]. Here, we attributed the 
restoring to opening of epoxide groups and hydrolysis of esters on the GO in basic 
condition during the activation treatment. This led to local changes in the 
microstructures of NGO with released local strain and increased conjugation in the 
GO sheets, causing increased optical absorption in the Vis-NIR range.  
The yellow brown color of our NGO solutions prompted us to investigate the 
photoluminescence of this material. Fluorescence measurement in the visible range 
revealed that the GO emission peaked at ~570nm at 400nm excitation (Fig. 2b). The 
emission maximum blue-shifted to ~520nm for NGO-PEG (Fig.2b). Chemical 
activation and PEGylation steps reduced the GO sheet size and changed the chemical 
functional groups on the sheets, which might be responsible for such shift. We probed 
into the IR and NIR regions and discovered photoluminescence (PL) of both GO and 
NGO-PEG in these regions (Fig. 2c&d). Fluorescence in the NIR is useful for cellular 
  6
imaging due to little cellular auto-fluorescence in this region, as shown with 
single-walled carbon nanotubes[15, 16]. 
We developed a density gradient ultracentrifugation method [17, 18] to separate 
the NGO-PEG sheets by size (Supp. Info. Fig. S1) and gained insight to the 
photoluminescence properties of NGO. By making use of the different sedimentation 
rate of different sized graphene in a density gradient, and by terminating the 
sedimentation at suitable time points, we captured different sized graphene sheets at 
different positions along the centrifuge-tube (Fig.2e). AFM of different fractions 
clearly indicated size separation of NGO-PEG sheets by our method (Fig.2f-h.). 
However, to our surprise, the different sized NGO sheets exhibited similar optical 
absorbance, photoluminescence and PLE spectra (Supp. Info. Fig.S2), without 
apparent quantum confinement effects expected due to the different physical sizes of 
the separated NGO sheets.  
This somewhat unexpected result suggested that small, conjugated aromatic 
domains existed on a NGO sheet. That is, small conjugated domains with various 
sizes (~1-5nm) coexist in a single, physically connected NGO sheet. Indeed, careful 
AFM imaging found small domain-like structures 1-5nm in size (Supp. Info. Fig.S3). 
Separation of NGO sheets by physical size afforded various fractions exhibiting 
similar photoluminescence since the NGO-PEG sheets contained similar smaller 
aromatic domains. The domain sizes were inhomogeneous and ranged from small 
aromatic molecules to large macromolecular domains. The former was responsible for 
fluorescence in the visible range, while the latter gave PL in IR range. The existence 
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of conjugated aromatic domains spaced by non-conjugated aliphatic six-members ring 
structures were found on GO by previous NMR experiments [19]. Nevertheless, our 
proposed photoluminescence mechanism is merely a suggestion, and requires further 
investigation. The resolution of size separation may also need significant 
improvement to observe quantum confinement effect, especially at the low end of the 
size distribution. Note that previously, carbon nanoparticles (1-5nm) after oxidative 
acid treatment exhibited fluorescence in the visible, and particle size and surface 
states significantly affected the fluorescence intensity and peak positions [20, 21]. The 
mechanism and chemical species responsible for the fluorescence also remained 
unclear [20, 21]. 
Fluorescent species in the NIR and IR range are potentially useful for 
biological applications since cells and tissues exhibit little auto-fluorescence in this 
region[16]. To this end, we covalently conjugated a B-cell specific antibody Rituxan 
(anti-CD20) to NGO-PEG (NGO-PEG-Rituxan) to selectively recognize and bind to 
B cell lymphoma cells (Fig. 3a)[16]. We incubated B-cells and T-cells in solutions of 
NGO-PEG-Rituxan conjugates at 4 °C to allow the conjugates to interact with the cell 
surface but block internalization via endocytosis [22]. The cells were then washed and 
imaged by detecting NIR photoluminescence from 1100 to 2200 nm using an InGaAs 
detector under 658 nm laser excitation (laser spot size ~1μm, see Methods). We 
detected the intrinsic NIR photoluminescence of NGO-PEG selectively on positive 
Raji B-cells surface (Fig.3b) and not on negative CEM T-cells (Fig.3c). This 
confirmed selective NGO-PEG-Ab binding to B-cells over T cells (Fig.3d). It also 
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established NGO as a NIR fluorophore for selective biological detections and imaging 
to take advantage of the little cellular auto-fluorescence in the NIR region [16, 23].  
The fluorescence quantum yield (QY) of the NGO-PEG was difficult to 
quantify due to the inhomogeneous species in the sample. As a preliminary attempt, 
we compared the total emitted light by Hipco SWNTs [24-26] and NGO-PEG in the 
900-1500 nm region under 785nm excitation, and observed similar light emission 
(within an order of magnitude) (Supp. Info. Fig. S4) normalized to the same 
absorbance at 785nm. Notably that for SWNTs, the quantum yield issue is also not 
well resolved due to sample inhomogenity, and is believed to be up to several percent 
for certain chiralities[24, 26]. Establishing the quantum yield of graphitic nanomaterials 
requires significant future effort including the improvement of material homogeneity 
and/or separation. 
Next, we explored using NGO as sheet-like vehicles to transport an aromatic 
anticancer drug doxorubicin (DOX) into cancer cells[27]. We first checked if 
NGO-PEG exhibit any toxicity by incubating Raji cells in various concentrations of 
NGO-PEG for 72 h. We observed slight reduction of cell viability only for extremely 
high NGO-PEG concentrations (>100mg/L) (supp. Info. Fig. S5). In our subsequent 
cellular experiments, we used only ~2mg/L of NGO-PEG, a concentration far below  
the level to cause any appreciable toxic effect to the cells.  
Rituxan (CD20+ antibody) conjugated NGO-PEG was used to target specific 
cancer cells for selective cellular killing (Fig.4a). The loading of DOX, a widely used 
chemotherapy drug for treating various cancers, was performed by simple mixing of a 
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NGO-PEG-Ab solution with DOX at pH 8 overnight, followed by repeated filtering to 
remove free, unbound DOX in solution. The formation of NGO-PEG/DOX was 
visible from the reddish color of the NGO-PEG/DOX solutions due to adsorbed DOX 
and its characteristic UV–vis absorbance peak at 490 nm on top of the NGO-PEG 
absorption spectrum (Fig.4b and inset). The loading of DOX onto NGO was attributed 
to simple π-stacking, similar to that in carbon nanotubes[27]. Under AFM, obvious 
thickness increase was observed as DOX was stacked onto graphene sheets (Supp. 
Info. Fig.S6). Compared to single-walled carbon nanotubes for drug loading via 
π-stacking[27], NGO is advantageous in low cost and high scalability[27]. 
Drug release from NGO-PEG sheets was observed as the chemical environment 
changed to acidic conditions. We found that ~40% of DOX loaded on NGO-PEG was 
released over 1 day in an acidic solution of pH 5.5 (Fig.4c), which was attributed to 
the increased hydrophilicity and solubility of DOX at this pH[27]. The release rate was 
slowed down as the pH was adjusted to pH 7.4, ~15% over 2 days. The pH-dependent 
drug release from NGO-PEG could be exploited for drug delivery applications since 
the micro-environments in the extracellular tissues of tumors and intracellular 
lysosomes and endosomes are acidic, which will afford active drug release from 
NGO-PEG delivery vehicles. 
For DOX loaded onto NGO-PEG-Rituxan, we incubated the conjugates with 
Raji cells at 2μM and 10μM DOX concentrations. Enhanced DOX delivery and cell 
killing was evidenced by comparison with Raji cells treated by free DOX, 
NGO-PEG/DOX without Rituxan, and a mixture of NGO-PEG/DOX and Rituxan 
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without covalent binding (Fig.4d). It should note that the in vitro selectivity is limited 
by the passive uptake of NGO-PEG/DOX. At higher DOX concentrations, the passive 
uptake is high so that cells are killed by either NGO-PEG/DOX or 
NGO-PEG-Rituxan/DOX. However a minimal DOX concentration is required to 
exhibit any biological effect. Therefore there is a dosage window in which the 
selective cell killing can be achieved. This is common for many other targeting drug 
delivery systems. We observed very good selective at [DOX]=10μM. The percentage 
of cell growth inhibition increased from ~20% in the NGO-PEG/DOX case to ~80% 
in the NGO-PEG-Rituxan/DOX case, which was a significant enhancement [27]. This 
result demonstrated the potential of selective killing of cancer cells using 
NGO-PEG-antibody/drug conjugates in vitro. 
 
Conclusions 
In summary, multifunctional biocompatible nano-graphene oxides with various 
physical sizes were prepared in a scalable manner. Photoluminescence of NGO from 
visible through infrared range was revealed and used for cellular imaging. Anti cancer 
drug was loaded onto NGO with high capacity, and selectively transported into 
specific cancer cells by antibody guided targeting. The novel graphitic nanostructures, 
combined with multi-functionalities including biocompatibility, photoluminescence 
and drug loading and delivery, suggest promising applications of graphene materials 
in biological and medical areas. 
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METHODS 
SYNTHESIS OF GRAPHENE OXIDE (GO) 
Graphene oxide (GO) was made by modified Hummer’s method[7] using expandable 
graphite flake (Graftech) as starting material[3]. 1g Expandable graphite flake was 
ground with 50g NaCl solids for 10 min. NaCl was dissolved and removed by 
filtration with water (lose ~15% carbon during this step). Ground expandable graphite 
flake (~0.85 g) was stirred in 23ml H2SO4 (98%) for 8h. 3g KMnO4 was gradually 
added while keeping temperature <20ºC. The mixture was stirred at 35-40ºC for 30 
min, then at 65-80ºC for 45min. Next, 46ml water was added and heated at 98-105ºC 
for 30 min. The reaction was terminated by addition of 140ml distilled water and 
10ml 30% H2O2 solution. The mixture was washed by repeated centrifuge and 
filtration, first with 5% HCl aqueous solution, then DI water. 160ml water was added 
to the final product and vortexed well to make an even suspension for storage. 
PEGYLATION OF GRAPHENE OXIDE 
For pegylation, 5ml GO aqueous solution was diluted by 2, and then bath sonicated 
for 1h to make a clear solution. 1.2g NaOH and 1.0g chloricacetic acid 
(Cl-CH2-COOH) was added into the 10ml GO suspension (~2mg/ml) and bath 
sonicated for 1-3 h [11] to convert the –OH groups to –COOH via conjugation of acetic 
acid moieties (named GO-COOH). The obtained GO-COOH solution was neutralized, 
and purified by rinsing and filtrations. GO-COOH suspension was diluted by water to 
make into optical density OD=0.4 at 808nm (1mm optical path). 2mg/ml 6-arm 
Polyetheylene Glycol-Amine (Sunbio Inc.) was added into GO-COOH suspension 
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and sonicated for 5min. N-(3-Dimethylaminopropyl-N’-ethylcarbodiimide 
hydrochloride (EDC, from Sigma Inc.) was added twice to reach 4mM and reacted 
overnight, then quenched by Mercaptoethanol (Fluka Inc.). The final product 
(NGO-PEG) was obtained by ultracentrifugation at 45k rpm in 2× phosphate buffered 
saline (PBS) for 1h to save the supernatant (yield ~50%). The aggregates were 
discarded. 
SEPARATION 
Rate separation in step density was used for NGO-PEG separation. In a typical 
experiment, OptiPrep® (60% (w/v) iodixanol, 1.32 g·cm-3) (Sigma-Aldrich Inc.) was 
diluted with water to make 5%, 10%, 15%, and 20% iodixanol solutions. Gradients 
were created directly in Beckman centrifuge tubes (polycarbonate, inner diameter 13 
mm, length 51 mm) by adding the 4 layers (0.6 mL each) to the tube bottom 
sequentially in the order of increasing density. Finally, 0.4 mL of 60% iodixanol was 
added to the bottom of the centrifuge tube to raise the height of the gradient in the 
centrifuge tube. 0.2 mL freshly made NGO-6PEG was layered on top of density 
gradient prior to ultracentrifugation. The typical centrifugation condition was 2.5 h at 
50k round per minute (~300kg). Calibrated micropipettors were used to manually 
sample 100 μL fractions along the centrifuge tube after ultracentrifugation. 
CHARACTERIZATION 
AFM was used for graphene oxide sheet size and thickness characterization. The 
optical properties of graphene oxide was characterized by 
ultraviolet-visible-near-infrared absorbance spectrometer (Varian Cary 6000i), 
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fluorescence spectrometer (Spex Fluorolog 3, λex = 400nmnm) and home built 
photoluminescence-excitation (PLE) spectrometer at room temperature [16].  
CELLULAR IMAGING 
Thiolated Rituxan was conjugated to the amine groups on NGO-PEG via a 
sulfo-SMCC linker (Pierce Inc.)[16]. For the cell incubation, 200 μl of CEM.NK T-cell 
and Raji B-cell (~1 million/ml) were incubated with 50 μl of NGO-PEG with or 
without Rituxan conjugation in PBS for 1h at 4o C. The NGO-PEG concentration in 
the solution during incubation was ~0.7mg/ml. Cells were washed with PBS 3 times 
to remove unbound NGO-PEG before use for NIR photoluminescence imaging. Cell 
samples prepared as described above were placed in a sample holder with a thin 
200μm quartz window. All NIR fluorescence images were taken using an inverted 
NIR fluorescence microscope in confocal mode.  Excitation from a diode laser at 
658 nm (Renishaw) was focused using a 100× IR coated objected lens (Olympus).  
The laser spot size width on the sample was about 1μm FWHM. The laser intensity at 
the sample was ~20mW. Emitted light was collected through the same objective and 
focused onto an OMA-V 1024 element linear InGaAs array (Princeton Instruments).  
The collected light went through a 900nm long pass filter (Omega) and a 1100nm 
long pass filter (ThorLabs) to block reflected excitation and reduce background 
fluorescence from the sample holder. High resolution images were taken by inserting 
a 50μm pinhole in the collection path, and 1 micron steps were taken in 2 directions. 
Background fluorescence from the sample holder (~160 counts) was subtracted to 
give relevant statistics about the effectiveness of NGO-PEG binding. 
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DRUG LOADING AND CELLULAR TOXICITY 
Doxorubicin (DOX) loading onto NGO-PEG (and NGO-PEG-Rituxan) was done by 
simply mixing 0.5mM of DOX with the NGO-PEG solution (~0.2mg/ml) at pH 8 
overnight. Unbound excess DOX was removed by filtration through a 100kDa filter 
and repeated rinse. The formed NGO-PEG/DOX complexes were re-suspended and 
stored at 4°C. Concentration of DOX loaded onto NGO-PEG was measured by the 
absorbance peak at 490 nm (characteristic of DOX, after subtracting the absorbance 
of NGO-PEG at that wavelength) with a molar extinction coefficient of 1.05 x104 
M·cm-1.  Both Raji and CEM cells were incubated with free DOX, NGO-PEG/DOX, 
NGO-PEG/DOX + Rituxan (unconjugated) and NGO-PEG-Ri/DOX at DOX 
concentrations of 2 μM or 10 μM for 2 hours and washed by PBS twice before 
transferring into fresh cell medium. After another 48h incubation, Cell viability was 
measured by the MTS assay with CellTiter96 kit (Promega). 
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FIGURE CAPTION  
Figure 1. Synthesis and pegylation of Nano- Graphene Oxide. (a) Schematic 
illustration of pegylation of graphene oxide by PEG-stars; (b)&(c) AFM images of 
GO and NGO-PEG, respectively; (d) IR spectra of GO, GO-COOH and NGO-PEG. 
(the black arrow indicated characteristic amide-carbonyl vibration.). 
 
Figure 2. Optical properties of nano- graphene oxide sheets. (a) UV-VIS-NIR 
absorbance spectra of GO, GO-COOH and NGO-PEG solutions with 0.01mg/ml 
graphitic carbon (1cm optical path). Inset: a photograph of GO and NGO-PEG 
solutions at the same graphitic carbon concentration to show visible color difference. 
(b) Fluorescence of GO (black curve) and NGO-PEG (red curve) in the visible range 
under an excitation of 400nm. (c)&(d) Photoluminescence excitation (PLE) spectra of 
GO & NGO-PEG with 0.31mg/ml graphitic carbon in the IR region (1mm optical 
path). The emission intensity at various emission wavelengths (x-axis) is represented 
by the color scheme shown as a function of excitation wavelength (y-axis). The data 
were obtained after normalization to detector sensitivity and absorbance curves. (e) A 
photograph of a ultracentrifuge-tube after density gradient separation of NGO-PEG. 
(f)-(h) AFM images of NGO-PEG fractions (F5, F13 and F23) at different locations in 
the centrifuge-tube as labeled in (e). 
 
Figure 3. Nano-graphene for targeted NIR imaging of live cells. 
(a) A schematic drawing illustrating the selective binding and cellular imaging of  
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NGO-PEG conjugated with anti-CD20 antibody, Rituxan; (b) NIR fluorescence image 
of CD20 positive Raji B-cells treated with the NGO-PEG-Rituxan.conjugate. Scale 
bar shows intensity of total NIR emission (in the range of 1100-2200 nm). Images are 
false-colored green. (c) NIR fluorescence image of CD20 negative CEM T-Cells 
treated with NGO-PEG-Rituxan conjugate. (d) Mean NIR fluorescence intensities in 
the image area for the both the positive (Raji) and negative (CEM) cells treated by 
NGO-PEG-Rituxan conjugate. 
 
Figure 4. Nano-graphene oxide for target drug delivery. (a) A schematic illustration of 
Doxorubicin (DOX) loading onto NGO-PEG-Rituxan via π-stacking. (b) 
UV-VIS-NIR absorbance spectra of NGO-PEG and NGO-PEG/DOX. DOX loading 
on NGO-PEG was evidenced by a strong absorption peak centered at ~490nm. 
Reddish color of the DOX loaded NGO-PEG is seen in the solution (see inset); (c) 
Doxorubicin retained on NGO-PEG over time in buffers at pH 5.5 and 7.4; (d) In vitro 
toxicity test at 2μM and 10μM DOX concentration to show Rituxan selectively 
enhanced doxorubicin delivery into Raji B-cells by comparing 
NGO-PEG-Rituxan/DOX with free DOX, mixture of DOX with NGO-PEG, and 
mixture of DOX, Rituxan and NGO-PEG. The viable cell percentage was measured 
by the MTS assay. 
  22
Figure 1 
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Figure 2 
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Figure 3 
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Figure 4 
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PEGylated graphene oxide with lateral dimension <10nm was obtained to afford 
solubility and stability in biological solutions including serum, and used for 
near-infrared cellular imaging and targeting drug delivery in vitro. 
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